UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042888
Receipt number R000048879
Scientific Title A Study of Left Whole Breast Irradiation with Deep Inhalation Cardiac Dose Reduction Method Using Infrared Rangefinder
Date of disclosure of the study information 2021/01/04
Last modified on 2021/12/09 11:25:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study of Left Whole Breast Irradiation with Deep Inhalation Cardiac Dose Reduction Method Using Infrared Rangefinder

Acronym

A Study of Deep Inhalation Cardiac Dose Reduction Method Using Infrared Rangefinder

Scientific Title

A Study of Left Whole Breast Irradiation with Deep Inhalation Cardiac Dose Reduction Method Using Infrared Rangefinder

Scientific Title:Acronym

A Study of Left Whole Breast Irradiation with Deep Inhalation Cardiac Dose Reduction Method Using Infrared Rangefinder

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Partial mastectomy and postoperative whole breast irradiation are commonly performed for early-stage breast cancer.
However, the heart is located on the dorsal side of the left breast, and if the heart is irradiated with a high dose, the incidence of cardiovascular disorders increases as a late adverse event.
Normally, radiation therapy is administered under free-breathing conditions, but irradiation during inspiration only can reduce the cardiac dose because the distance between the breast and the heart is greater than under free-breathing conditions.
While insufflation irradiation can reduce the cardiac dose, since insufflation is stopped and irradiation is performed multiple times in one irradiation, reproducibility of the insufflation breath-hold state (position of the rib cage and heart) each time is important. If the reproducibility of the inhalation volume is low, the dose to the irradiation target volume and the cardiac dose reduction effect will be reduced, and various methods have been tried to confirm the reproducibility of the inhalation in this irradiation method.
In this study, we prepared a relatively inexpensive device for confirming respiratory reproducibility by using an infrared rangefinder, and aim to ensure reproducibility during deep inspiration during left breast irradiation using this method.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Inhalation reproducibility when irradiated during inhalation using an infrared distance meter

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Irradiate during inhalation using an infrared distance meter.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

The patient had a partial left mastectomy and was undergoing whole breast irradiation.
The patient has a left nipple (not after papillotomy).
The patient is between 20 and 60 years old at the time of the first visit to our department.
ECOG PS is 0 or 1.
The patient can hold his/her breath for more than 20 seconds.

Key exclusion criteria

Pain prevents the patient from maintaining external rest for 10 minutes.
Has a history of active collagen disease.
She is pregnant.
Has a postoperative pacemaker.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Naoto
Middle name Ohshima
Last name Shikama

Organization

Juntendo university

Division name

Department of Radiation Oncology

Zip code

1130033

Address

Bunkyo Hongo 3-1-1

TEL

0338133111

Email

n-shikama@juntendo.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name Ohshima
Last name Oshima

Organization

Juntendo university

Division name

Department of Radiation Oncology

Zip code

1130033

Address

Bunkyo Hongo 3-1-1

TEL

0338133111

Homepage URL


Email

msoosima@juntendo.ac.jp


Sponsor or person

Institute

Juntendo university

Institute

Department

Personal name



Funding Source

Organization

Juntendo university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University

Address

Tokyo Bunkyo Hongo 3-1-1

Tel

09055104845

Email

msoosima@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

22

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 12 Month 01 Day

Date of IRB

2020 Year 12 Month 01 Day

Anticipated trial start date

2020 Year 12 Month 22 Day

Last follow-up date

2021 Year 11 Month 01 Day

Date of closure to data entry

2021 Year 11 Month 01 Day

Date trial data considered complete

2021 Year 11 Month 01 Day

Date analysis concluded

2021 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2021 Year 01 Month 03 Day

Last modified on

2021 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048879


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name